BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.87B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.2B |
| 3 |
Amazon
AMZN
|
+$1.9B |
| 4 |
NVIDIA
NVDA
|
+$1.86B |
| 5 |
Costco
COST
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.53B |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$1.81B |
| 3 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$732M |
| 4 |
Super Micro Computer
SMCI
|
+$728M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Vita Coco
COCO
$3.77B
| $67.8M | ﹤0.01% |
2,777,218
+524,416
| +23% | +$12.2M |
|
2277
Viper Energy
VNOM
$14.8B
| $67.6M | ﹤0.01% |
1,757,844
+1,487,401
| +550% | +$50.3M |
|
|
CWAN
2278
DELISTED
Clearwater Analytics
CWAN
| $67.4M | ﹤0.01% |
3,811,721
+552,747
| +17% | +$10.3M |
|
2279
Nurix Therapeutics
NRIX
$2.82B
| $67.3M | ﹤0.01% |
4,580,414
-63,322
| -1% | -$681K |
|
|
LGF.A
2280
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $67.2M | ﹤0.01% |
6,749,367
-176,890
| -3% | -$1.75M |
|
2281
Medifast
MED
$128M
| $67.1M | ﹤0.01% |
1,751,913
-53,108
| -3% | -$2.57M |
|
2282
Fate Therapeutics
FATE
$294M
| $66.8M | ﹤0.01% |
9,099,951
-2,112,865
| -19% | -$13.1M |
|
2283
Viridian Therapeutics
VRDN
$2.49B
| $66.8M | ﹤0.01% |
3,812,630
+386,180
| +11% | +$7.49M |
|
2284
Gorman-Rupp
GRC
$2.11B
| $66.6M | ﹤0.01% |
1,685,062
-24,673
| -1% | -$881K |
|
2285
First Advantage
FA
$3.81B
| $66.5M | ﹤0.01% |
4,100,653
-96,076
| -2% | -$1.57M |
|
2286
Amalgamated Financial
AMAL
$1.53B
| $66.4M | ﹤0.01% |
2,767,872
-119,819
| -4% | -$2.94M |
|
2287
Transcat
TRNS
$888M
| $66.3M | ﹤0.01% |
594,627
-3,730
| -0.6% | -$395K |
|
|
VMEO
2288
DELISTED
Vimeo
VMEO
| $66.2M | ﹤0.01% |
16,179,916
+3,685,609
| +29% | +$15.7M |
|
|
MRUS
2289
DELISTED
Merus
MRUS
| $66.1M | ﹤0.01% |
1,467,924
+38,031
| +3% | +$1.54M |
|
|
NKLA
2290
DELISTED
Nikola Corporation Common Stock
NKLA
| $66.1M | ﹤0.01% |
2,117,242
+313,300
| +17% | +$6.73M |
|
2291
Shinhan Financial Group
SHG
$35.1B
| $66.1M | ﹤0.01% |
1,861,215
+24,027
| +1% | +$777K |
|
2292
Arcutis Biotherapeutics
ARQT
$3.25B
| $66M | ﹤0.01% |
6,658,741
+742,195
| +13% | +$5.54M |
|
2293
Tootsie Roll Industries
TR
$3.02B
| $66M | ﹤0.01% |
2,185,612
-18,076
| -0.8% | -$548K |
|
|
AMK
2294
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $65.9M | ﹤0.01% |
1,861,226
-75,945
| -4% | -$2.48M |
|
2295
Liquidity Services
LQDT
$1.35B
| $65.3M | ﹤0.01% |
3,513,083
+27,716
| +0.8% | +$481K |
|
2296
Lennar Class B
LEN.B
$20.7B
| $65.2M | ﹤0.01% |
445,113
+14,674
| +3% | +$1.99M |
|
2297
Lemonade
LMND
$4.1B
| $65.2M | ﹤0.01% |
3,975,211
-90,256
| -2% | -$1.52M |
|
2298
United States Lime & Minerals
USLM
$3.37B
| $65.2M | ﹤0.01% |
1,093,335
+248,570
| +29% | +$12.8M |
|
2299
Manitowoc
MTW
$753M
| $64.7M | ﹤0.01% |
4,573,865
+177,071
| +4% | +$2.63M |
|
2300
Cadre Holdings
CDRE
$1.45B
| $64.6M | ﹤0.01% |
1,784,586
+68,398
| +4% | +$2.38M |
|
Similar funds
BlackRock's Q1 2024 Portfolio in Review
As of Q1 2024, BlackRock held 5,499 positions worth $4.3T, up 9.5% from $3.92T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BlackRock's Q1 2024 filing shows 129 new, 1,833 increased, 2,801 reduced and 210 closed positions. Its largest new stake was Arcadium Lithium plc: 122,471,992 shares worth $528M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.53B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2024 buy was Arcadium Lithium plc: 122,471,992 shares worth $528M.
- BlackRock added most to Microsoft in Q1 2024, an estimated $2.87B increase.
- BlackRock's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.53B.
- BlackRock fully exited Splunk Inc in Q1 2024, selling an estimated $1.81B.
- BlackRock's ten largest holdings make up 24% of its $4.3T portfolio in Q1 2024.
- BlackRock opened 129 new positions and closed 210 in Q1 2024.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $4.3T.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.